CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
26 hedge funds and large institutions have $74.3M invested in Cymabay Therapeutics in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
26
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.34M | |
| 2 | +$5.61M | |
| 3 | +$3.51M | |
| 4 |
VAM
Visium Asset Management
New York
|
+$3.33M |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$1.17M |
Top Sellers
| 1 | -$3.51M | |
| 2 | -$1.97M | |
| 3 | -$983K | |
| 4 |
Jennison Associates
New York
|
-$63.9K |
| 5 |
Barclays
London,
United Kingdom
|
-$14K |